US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

17.74

-0.0600-0.34%

Post-market: 17.800.0600+0.34%19:30 EDT

Volume:28.78K

Turnover:509.79K

Market Cap:104.67M

PE:- -

High:17.93

Open:17.89

Low:17.60

Close:17.80

52wk High:21.50

52wk Low:14.38

Shares:5.90M

Float Shares:5.90M

Volume Ratio:0.55

T/O Rate:0.49%

Dividend:0.71

Dividend Rate:4.03%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Akeso (SEHK:9926) Could Be 47% Undervalued As China Approves Ivonescimab Use

Simply Wall St.

CSPC Pharmaceutical Group Stock Sheds 1.3% in Hong Kong, Underperforms Competitors

Wuxi Biologics (Cayman) Stock Falls 1.4% in Hong Kong

Does FDA-Backed Mpox mRNA Trial and AstraZeneca Tie-Up Recast the Bull Case For CSPC (SEHK:1093)?

Simply Wall St.

Innovent Biologics (SEHK:1801), Why Is It Back In The Spotlight?

Simply Wall St.

CSPC Pharma Says NMPA Accepts NDA for KN026 and Hb1801 for Advanced Breast Cancer

Global Food Inflation Risks Return While Robotics Stocks Rally on Yushu Tech's Upcoming Debut

CSPC Pharma Unit's Breast Cancer Drug Application Granted Priority Review in China

MT Newswires Live

Beone Medicines Rises 1.34% With H1 Revenue Reaching 22.2 Billion Yuan as Global Expansion Accelerates

Alphamab Oncology Says China NMPA Accepts Anbenitamab NDA for First-Line HER2+ Advanced Breast Cancer

CSPC Pharmaceutical - Kn026 and Hb1801 Combination Previously Granted Breakthrough Therapy Designation by Nmpa

THOMSON REUTERS

CSPC Pharmaceutical - Nda Indication: First-Line Treatment of Unresectable or Metastatic Her2-Positive Breast Cancer

THOMSON REUTERS

WuXi Biologics Wins BioPharma APAC Spot on 2026 Sustainable Biopharma List

WuXi XDC Secures GMP Release for BCM3 Bioconjugate Production Line in Singapore

CSPC Innovation Posts RMB 1.26 Billion H1 Net Profit on RMB 3.24 Billion Revenue

BlackRock Expands Stake in INNOVENT BIO with Recent Share Purchase

CSPC Innovation Pharmaceutical H1 Net Profit 1.3 Billion Yuan

Wuxi Biologics (Cayman) Stock Rises 2.3% in Hong Kong

WuXi Biologics Agrees to Sell 51.1% Stake in Bestchrom

JPMorgan Chase & Co. Increases Stake in BEONE MEDICINES by Over 4.1 Million Shares at Approximately HKD 219.79 Each

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/KURE/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":17.74,"timestamp":1789156800000,"preClose":17.8,"halted":0,"volume":28778,"hourTrading":{"tag":"盘后","latestPrice":17.8,"preClose":17.74,"latestTime":"19:30 EDT","volume":110,"amount":1957.48,"timestamp":1789169406504,"change":0.06,"changeRate":0.003382,"amplitude":0.003382},"delay":0,"changeRate":-0.00337078651685406,"floatShares":5900168,"shares":5900168,"eps":0,"marketStatus":"Market Closed","change":-0.06,"latestTime":"09-11 16:00:00 EDT","open":17.89,"high":17.93,"low":17.6,"amount":509789.147232,"amplitude":0.018539,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":17.8,"sharesOutstanding":4750002,"nav":17.98,"aum":106101372.73,"dividendRate":0.040293,"bidAskSpread":0.008302,"postHourTrading":{"tag":"盘后","latestPrice":17.8,"preClose":17.74,"latestTime":"19:30 EDT","volume":110,"amount":1957.48,"timestamp":1789169406504,"change":0.06,"changeRate":0.003382,"amplitude":0.003382},"volumeRatio":0.5515710695008692,"impliedVol":0.3113,"impliedVolPercentile":0.6295},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5900168,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5515710695008692,"shares":5900168,"dividePrice":0.7148,"high":17.93,"amplitude":0.018539,"preClose":17.8,"low":17.6,"week52Low":14.3797,"pbRate":"--","week52High":21.5,"institutionHeld":0,"latestPrice":17.74,"eps":0,"divideRate":0.040293,"volume":28778,"delay":0,"ttmEps":0,"open":17.89,"prevYearClose":17.04,"prevWeekClose":18.9,"prevMonthClose":18.54,"prevQuarterClose":15.747,"fiveDayClose":18.91,"twentyDayClose":18.66,"sixtyDayClose":14.875},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660244894","title":"Akeso (SEHK:9926) Could Be 47% Undervalued As China Approves Ivonescimab Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2660244894","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660244894?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:20","pubTimestamp":1787149244,"startTime":"0","endTime":"0","summary":"Akeso (SEHK:9926) is back in focus after China’s National Medical Products Administration approved ivonescimab plus chemotherapy as a first-line treatment for advanced squamous non-small cell lung cancer.\nSee our latest analysis for Akeso.\nDespite the positive ivonescimab news, Akeso’s share price has come under pressure, with the stock down 12.54% over the past week and 21.18% year to date. At the same time, the 3 year total shareholder return of 185.76% and 5 year total shareholder return...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-47-undervalued-as-china-approves-ivo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-47-undervalued-as-china-approves-ivo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0348783233.USD","LU1794554557.SGD","LU2399975544.HKD","LU0417516738.SGD","LU2476274720.SGD","LU2488822045.USD","LU0417516571.SGD","BK1161","LU0348735423.USD","LU1961090484.USD","LU0348784397.USD","BK1574","LU0561508036.HKD","LU2778985437.USD","LU0348766576.USD","LU0417516902.SGD","LU0348767384.USD","IE00BPRC5H50.USD","LU2476274308.USD","LU0348827113.USD","09926","LU0348825331.USD","LU0540923850.HKD","LU0634319403.HKD","LU1720050803.USD","IE00B543WZ88.USD","KURE","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660453474","title":"CSPC Pharmaceutical Group Stock Sheds 1.3% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660453474","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660453474?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:33","pubTimestamp":1787128380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. slipped 1.3% to 8.69 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.1% to 25495.07.The stock's fall snapped a two-day winning streak.CSPC Pharmaceutical Group Ltd. closed 25% below its 52-week high of HK$11.63, which the company achieved Sept. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 0.1%, SSY Group Ltd. fell 0.6%, and United Laboratories International Holdings Ltd. fell 1.4%.Trading volume totaled 67.4 million shares, compared to the 50-day average of 92.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YT58.USD","LU0314109678.HKD","LU1813983027.USD","IE00B543WZ88.USD","LU1152091754.HKD","LU1152091168.USD","LU0067412154.USD","KURE","BK1515","LU0501845795.SGD","01093","LU1328277881.USD","LU0880133367.SGD","IE00BZ08YS42.EUR","SG9999004220.SGD","IE0008369823.USD","BK1191","IE00B5MMRT66.SGD","LU1807302812.USD","LU1960683339.HKD","LU0326950275.SGD","LU1226287529.USD","LU1993786604.SGD","LU1226288253.USD","LU1008478684.HKD","HK0000165453.HKD","BK1521","IE00B031HY20.USD","LU1226287875.USD","IE0008368742.USD","IE00BZ08YR35.GBP","LU1951186391.HKD","LU0072913022.USD","LU2039709279.SGD","LU0315179316.USD","LU1226287792.SGD","LU0140636845.USD","LU1226288170.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660445379","title":"Wuxi Biologics (Cayman) Stock Falls 1.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2660445379","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660445379?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:33","pubTimestamp":1787128380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. slipped 1.4% to 47.90 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.1% to 25495.07.The stock's fall snapped a two-day winning streak.Wuxi Biologics  Inc. closed 2.2% below its 52-week high of HK$49.00, which the company achieved Aug. 18.Trading volume totaled 32.0 million shares, compared to the 50-day average of 35.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","LU0417516902.SGD","LU0588546209.SGD","LU0819121731.USD","LU1794554557.SGD","BK1521","SG9999002562.SGD","LU0029874061.USD","LU1242518857.USD","IE00B0JY6N72.USD","LU2039709279.SGD","LU0516423174.USD","LU0326950275.SGD","LU0979878070.USD","LU0572944931.SGD","LU0823426308.USD","LU0348735423.USD","LU0181495838.USD","BK1610","LU0823426480.USD","LU0348825331.USD","LU0417516738.SGD","LU0052750758.USD","LU0039217434.USD","LU0320764599.SGD","LU0359202008.SGD","LU0051755006.USD","LU0327786744.USD","LU0456827905.SGD","LU1242518931.SGD","LU0140636845.USD","LU0359201612.USD","LU0856984785.SGD","BK1576","BK1141","LU1720050803.USD","LU0516422440.USD","LU1880383366.USD","LU0516422366.SGD","LU0128526141.USD","SG9999002463.SGD","LU0516422952.EUR","02269","LU3063872942.SGD","KURE","LU0708995583.HKD","LU1688375341.USD","LU0456846285.SGD","LU0043850808.USD","LU0307460666.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480614","title":"Does FDA-Backed Mpox mRNA Trial and AstraZeneca Tie-Up Recast the Bull Case For CSPC (SEHK:1093)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480614","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480614?lang=en_us&edition=fundamental","pubTime":"2026-08-19 13:12","pubTimestamp":1787116367,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group recently reported three developments: U.S. FDA approval to begin clinical trials for its mpox mRNA vaccine, a US$10,000,000 milestone payment from AstraZeneca tied to their small-molecule collaboration, and a joint venture with AstraZeneca to build a biologics manufacturing facility in Shijiazhuang, China.\nTogether, these moves expand CSPC’s innovative vaccine and drug pipeline while pushing its manufacturing and quality systems further onto the global stage.\nWe’ll...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/does-fda-backed-mpox-mrna-trial-and-astrazeneca-tie-up-recas","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1093/cspc-pharmaceutical-group-shares/news/does-fda-backed-mpox-mrna-trial-and-astrazeneca-tie-up-recas","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BZ08YT58.USD","LU1226287875.USD","LU1328277881.USD","LU0501845795.SGD","LU0067412154.USD","LU1993786604.SGD","LU1960683339.HKD","LU0140636845.USD","IE0008369823.USD","BK4588","LU0315179316.USD","LU1008478684.HKD","BK4585","IE00BZ08YR35.GBP","LU1152091168.USD","LU1226287792.SGD","IE00B543WZ88.USD","LU0880133367.SGD","IE0008368742.USD","LU1226288170.HKD","SG9999004220.SGD","LU0072913022.USD","BK1521","KURE","LU1152091754.HKD","LU1951186391.HKD","LU1807302812.USD","IE00B5MMRT66.SGD","IE00B031HY20.USD","LU1226288253.USD","LU0314109678.HKD","LU2039709279.SGD","IE00BZ08YS42.EUR","01093","LU1226287529.USD","HK0000165453.HKD","BK1191","LU1813983027.USD","LU0326950275.SGD","BK1515","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660494056","title":"Innovent Biologics (SEHK:1801), Why Is It Back In The Spotlight?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660494056","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660494056?lang=en_us&edition=fundamental","pubTime":"2026-08-19 00:24","pubTimestamp":1787070276,"startTime":"0","endTime":"0","summary":"Innovent Biologics (SEHK:1801) caught investor attention after reporting product revenue of over CN¥4.3b for Q2 2026 and more than CN¥8.2b for the first half, supported by its dual engine growth strategy.\nSee our latest analysis for Innovent Biologics.\nThose revenue headlines have arrived alongside firm share price momentum, with Innovent Biologics delivering a 30 day share price return of 8.66% and a 90 day share price return of 21.73%, while the three year total shareholder return of...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/innovent-biologics-sehk1801-why-is-it-back-in-the-spotlight","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/innovent-biologics-sehk1801-why-is-it-back-in-the-spotlight","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["01801","LU0326950275.SGD","LU0244354667.USD","LU2097828631.EUR","LU2097828474.EUR","LU0455707207.USD","BK1583","BK1161","LU2097828805.USD","LU2242644610.SGD","LU1188198961.HKD","LU1969619763.USD","LU0502904849.HKD","LU0463099449.HKD","BK1589","LU2097828557.USD","HK0000165453.HKD","KURE","LU2097828714.EUR","LU2488822045.USD","LU2328871848.SGD","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660951444","title":"CSPC Pharma Says NMPA Accepts NDA for KN026 and Hb1801 for Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660951444","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660951444?lang=en_us&edition=fundamental","pubTime":"2026-08-18 23:22","pubTimestamp":1787066521,"startTime":"0","endTime":"0","summary":"BRIEF-CSPC Pharma Says NMPA Accepts NDA For KN026 And HB1801 For Advanced Breast CancerAug 18 (Reuters)-CSPC PHARMACEUTICAL GROUP LIMITED1093.HK:NMPA ACCEPTS NEW DRUG APPLICATION FOR KN026 AND HB1801 FOR ADVANCED BREAST CANCERFurther company coverage:1093.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F0K4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","LU1807302812.USD","BK1191","IE0008368742.USD","LU0880133367.SGD","BK1515","LU1226288253.USD","LU1960683339.HKD","LU1226288170.HKD","01093","IE00B031HY20.USD","LU0067412154.USD","IE00B543WZ88.USD","BK1521","IE00B5MMRT66.SGD","LU0072913022.USD","LU1993786604.SGD","LU1152091168.USD","LU1226287875.USD","LU1226287792.SGD","LU1226287529.USD","LU1328277881.USD","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","LU0315179316.USD","LU0326950275.SGD","LU0314109678.HKD","LU2039709279.SGD","SG9999004220.SGD","KURE","HK0000165453.HKD","LU0140636845.USD","LU1813983027.USD","LU1008478684.HKD","IE0008369823.USD","LU1152091754.HKD","LU1951186391.HKD","LU0501845795.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108049588","title":"Global Food Inflation Risks Return While Robotics Stocks Rally on Yushu Tech's Upcoming Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=1108049588","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108049588?lang=en_us&edition=fundamental","pubTime":"2026-08-18 21:04","pubTimestamp":1787058250,"startTime":"0","endTime":"0","summary":"External uncertainties persisted, yet both markets demonstrated resilience as Hong Kong equities edged up 0.07% on the day. The 60-day negotiation window outlined in the US-Iran memorandum of...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0509642566.USD","BK1191","LU0106959298.USD","LU0823426308.USD","SOCL","LU0972618739.USD","SG9999001903.USD","LU0211331839.USD","LU0329678337.USD","LU0048580855.USD","IE00B3M56506.USD","LU1105468828.SGD","LU3227948356.SGD","SG9999003461.SGD","LU2097829019.USD","LU0469268626.HKD","LU0898667661.SGD","IE00BZ08YR35.GBP","LU0611395673.USD","SGXZ51526630.SGD","LU2498475776.HKD","LU0737861772.HKD","LU1785774172.SGD","LU2357305700.SGD","SG9999002562.SGD","SGXZ62798434.SGD","LU0828237510.HKD","IE00B0169L03.USD","LU0588545490.SGD","LU0043850808.USD","LU0314109678.HKD","LU0463099449.HKD","LU0173614495.USD","BIDD","BK1615","IE00B543WZ88.USD","LU2125910849.SGD","LU2279701549.SGD","LU2251237488.HKD","LU0449509016.USD","LU1008478684.HKD","LU1814569148.SGD","LU0791590937.USD","LU1171460220.USD","LU2087589342.USD","SG9999006597.SGD","LU0130518102.USD","LU0630378692.HKD","LU1366334651.USD","SG9999007991.SGD","BK1249","LU2257852520.SGD","LU1883866441.USD","LU0594300419.USD","LU0499858602.USD","LU0130103400.USD","SG9999001689.USD","LU0070217475.USD","LU0210526637.USD","SEA","LU0516422440.USD","BK1531","LU1048588211.SGD","IE0032431581.USD","BK1212","LU1770036033.HKD","02050","CXSE","IE00BQXX3F31.USD","SG9999001093.SGD","IE00B29SXG58.USD","BK1575","SG9999002828.SGD","LU2778985437.USD","SG9999015978.USD","LU0320764755.SGD","BK1610","LU0588545730.USD","TCHmain","LU0169518387.USD","02268","LU0873338254.USD","LU0084288322.USD","00700","LU0708995583.HKD","LU0326948709.USD","BK1183","LU0516423091.SGD","LU0593848301.USD","LU0054450605.USD","LU0577902371.SGD","LU1282649067.USD","LU2039709279.SGD","LU3063872942.SGD","EMCS","LU0067412154.USD","EEMX","LU0516422952.EUR","LU0501845795.SGD","SGXZ90724238.SGD","LU0348816934.USD","LU1720050803.USD","LU0823041008.USD","LU0348814723.USD","LU0054237671.USD","LU0244354667.USD","BK1576","LU0823397103.USD","FDNI","LU1251922891.USD","LU0359202008.SGD","LU0227179875.USD","LU0762540952.USD","LU1794554557.SGD","LU1515016050.SGD","LU0588546209.SGD","SG9999002463.SGD","LU1868838027.USD","IE00BMPRXR70.SGD","LU0259732245.USD","LU0417516902.SGD","00354","LU0326950275.SGD","LU0882747503.HKD","IE00B031HW06.USD","LU0328353924.USD","LU0132412106.USD","JEMA","IE0034224299.USD","LU0651946864.USD","IE00BQXX3D17.EUR","LU0163747925.USD","LU0862451837.USD","LU0072462343.USD","LU2008162690.USD","LU0048388663.USD","BK1541","SG9999001226.SGD","LU1051768304.USD","LU0320764599.SGD","HK0000306685.HKD","LU0488056044.USD","01117","LU0345769128.USD","LU0149534421.HKD","LU1282651121.HKD","LU1880398554.USD","BK1171","LU1051769294.HKD","LU1328615791.USD","02419","LU1719994722.HKD","LU2251237306.USD","LU2237443622.USD","SG9999013353.USD","LU0287142896.SGD","09858","LU0540923850.HKD","SGXZ99366536.SGD","002050","LU0797268264.HKD","BK1587","LU1974910355.USD","IE0003795394.USD","LU0396098781.USD","BK1155","KURE","LU2097828714.EUR","LU0192582467.USD","LU1688375341.USD","LU0878004406.USD","LU0047713382.USD","01308","WXXWY","LU0029874905.USD","LU0228659784.USD","BK1104","LU1956131251.USD","LU0348825331.USD","HK0000151867.HKD","LU0577902298.EUR","IE0001KFT4U8.USD","LU2097828631.EUR","IE00BZ08YS42.EUR","LU0648948544.HKD","BK1583","GB00BDT5M118.USD","LU0107464264.USD","LU0165289439.USD","IE00B031HY20.USD","SG9999011746.SGD","LU0572940350.SGD","LU1734074674.USD","LU1718418525.SGD","LU0348783233.USD","BK1144","IE0008368304.USD","LU0589944569.HKD","LU2177674079.SGD","LU0128526141.USD","LU0143863784.USD","LU0708995153.HKD","02510","LU1675838814.USD","LU0164872284.USD","LU1568876335.HKD","SG9999014914.USD","IE0031814852.USD","SG9999001069.SGD","SG9999001846.SGD","LU0269904917.USD","LU1046422090.SGD","LU0828238088.HKD","00631","LU2045819591.USD","FFEM","LU1328277881.USD","LU2226246903.HKD","LU1226287529.USD","LU0203345920.USD","LU0648000940.SGD","LU1023057109.AUD","BK1608","LU1548497426.USD","LU1224444064.USD","LU0181495838.USD","LU0327786744.USD","LU0441854154.USD","LU1720051108.HKD","LU0630378429.USD","BK1553","LU0315179316.USD","IE00B031J352.USD","LU0029874061.USD","LU0605514214.HKD","LU2293587155.HKD","LU0918141705.HKD","LU0106259558.USD","LU0828237940.HKD","DRGN","LU0072913022.USD","688836","LU0417516738.SGD","LU0608807946.USD","LU0348784397.USD","BK1516","BK1237","BK1526","LU0175139822.USD","LU1568876251.USD","SG9999000418.SGD","HK0000252152.HKD","LU0979878070.USD","LU0577902538.SGD","LU0607220059.USD","LU2237443978.SGD","LU1152091168.USD","LU0029875118.USD","HK0001040143.USD","03888","LU0862451753.SGD","LU1201861165.SGD","LU0203347892.USD","LU2148510915.USD","LU0819121731.USD","LU1868837722.USD","LU1770034418.SGD","HK0000352382.USD","IE0003895053.USD","LU0784639295.USD","LU0370786039.SGD","LU1439103000.SGD","LU0634319403.HKD","LU1961090484.USD","LU0543330483.HKD","LU1831875114.USD","HK0000320264.USD","002747","LU0414403682.SGD","LU1725190679.HKD","LU0052750758.USD","ALBmain","SG9999015986.USD","SG9999004220.SGD","LU0823040885.USD","LU0572939691.SGD","LU0231483743.USD","BK1502","OROVY","LU0449515922.USD","IE0009570106.USD","LU0683595622.HKD","IE0008368742.USD","HK0000107257.USD","LU0048597586.USD","LU1733274390.USD","HK0001040168.HKD","LU0384037296.USD","IE00BGV7N243.SGD","03952","LU1808992512.USD","LU1226287792.SGD","LU0577902454.USD","LU0823413660.USD","LU1211504680.USD","LU0117841782.USD","LU1880383440.USD","06821","LU0080751232.USD","IE00BZ08YT58.USD","LU2237443382.USD","LU0061477393.USD","LU1048484197.HKD","LU2242644610.SGD","LU0117844026.USD","LU0608807433.USD","LU0261947096.USD","LU0700851271.USD","LU1813983027.USD","LKHLY","LU0541502299.USD","LU0516422366.SGD","LU0096374516.USD","LU1196710351.USD","LU0572944931.SGD","LU0577902611.USD","LU0127658192.USD","LU0039217434.USD","BK1521","LU1044876610.USD","LU1769817096.USD","LU1316542783.SGD","BK1586","LU0211977185.USD","EMC","SG9999018857.SGD","LU0293314216.USD","LU1733274473.HKD","LU0235996351.USD","LU1868837565.USD","LU0307460666.USD","LU1064131003.USD","SG9999014674.SGD","LU1951186391.HKD","HK0000306701.USD","AAXJ","LU0672654166.SGD","LU0786609619.USD","LU1993786604.SGD","IE00BQXX3C00.GBP","LU1439102457.SGD","LU1235295612.USD","LU0345775950.USD","LU0985320562.USD","LU0675040207.SGD","LU0264606111.USD","HK0000352291.HKD","02715","LU0543330566.HKD","TCEHY","IE00B12V2V27.USD","LU2051468812.USD","LU0431992006.USD","LDEM","LU2462611646.USD","LU0106252389.USD","LU0737861699.HKD","LU1720051017.SGD","LU0819123356.HKD","IE00BPRC5H50.USD","LU0143863198.USD","LU0823397285.USD","LU1282649141.HKD","LU1981816686.USD","SG9999014880.SGD","SG9999000459.SGD","LU1960683339.HKD","LU0228367735.SGD","ROBO","LU2097828557.USD","SG9999002950.SGD","SGXZ81514606.USD","LU2317271919.USD","LU1655091459.SGD","LU0456846285.SGD","TCHI","BK1095","LU0345769631.USD","LU1048596156.SGD","LU1242518931.SGD","LU1810669033.SGD","00316","SG9999015952.SGD","BABA","LU0049853897.USD","LU1226288253.USD","IE00B0169N27.USD","IE00BYTNYN87.SGD","LU1115378108.SGD","LU1629966141.USD","LU0456827905.SGD","LU2125910500.SGD","LU0051755006.USD","LU2237443549.SGD","LU1064130708.USD","BKF","HK0000914660.USD","LU0762541174.USD","LU0633140560.USD","LU0516423174.USD","LU1226287875.USD","IE0008368411.USD","LU0348783662.USD","LU2152927971.USD","LU0831103253.SGD","IE00BYQNZ168.SGD","LU0315178854.USD","SGXZ31699556.SGD","GAMR","SG9999000327.SGD","LU0886674414.USD","BK1589","BK1141","SG9999014906.USD","LU0197773160.USD","HK0000252160.HKD","HK0000500386.USD","LU0348735423.USD","LU0320764243.SGD","LU0561508036.HKD","LU0594300179.USD","LU1880383366.USD","LU1691799644.USD","LU0871576103.HKD","09676","LU0289960550.SGD","LU0633140727.USD","LU0261950983.USD","LU1102505762.USD","LU0197773673.USD","HK0000914686.HKD","LU0417516571.SGD","LU2279858448.HKD","ESPO","LU0348827113.USD","LU1152091754.HKD","SG9999017495.SGD","LU0831093199.SGD","LU1282648689.USD","IE00B0JY6N72.USD","BK1607","LU2237443465.HKD","LU1282649810.SGD","HTCD.SI","LU0149721374.USD","LU1642822792.SGD","XSOE","LU0918141887.USD","BK1517","SG9999015945.SGD","LU0531970944.HKD","LU2488822045.USD","LU0128522157.USD","LU0456842615.SGD","LU0251144936.SGD","LU0477156797.USD","BK1505","LU2097828805.USD","IE00B8L5B284.USD","LU0865486749.SGD","LU2133065610.SGD","LU2023250504.SGD","300759","LU2106854487.HKD","LU2265009873.SGD","BK1588","LU1917777945.USD","LU0348788117.USD","LU1044875133.USD","BOAT","LU1226288097.SGD","LU0128522744.USD","LU0359201612.USD","LU0348805143.USD","IE0032834883.USD","LU2449936058.SGD","LU1880398471.USD","BK1548","LU0878005551.USD","LU2237443895.HKD","BK1618","LU0049112450.USD","LU0188438112.USD","LU0890818403.SGD","LU0329678170.USD","IE00B8HQ1Z84.USD","LU0588545904.SGD","LU0011963245.USD","LU0214875030.USD","LU0650527681.SGD","LU1769817179.HKD","LU0254981946.USD","LU1102505929.USD","LU2247934214.USD","LU0823426480.USD","BK1509","IE00B5MMRT66.SGD","LU2476274308.USD","SG9999001051.SGD","LU1366334578.USD","LU0823038988.USD","LU1323998911.USD","SG9999006514.SGD","01548","LU0823039010.USD","HK0000320223.HKD","LU0880133367.SGD","LU0345776255.USD","LU0164880469.USD","LU0762542818.HKD","LU2097828474.EUR","03759","LU1044874839.SGD","LU0164865239.USD","JADE","LU0651947912.USD","LU1224709979.USD","LU0348723411.USD","89988","SG9999018865.SGD","LU0210533765.USD","BK1142","LU0823413587.USD","LU1196710195.USD","09988","BK1584","LU0455707207.USD","LU0821914370.USD","BK1501","LU1282651048.USD","LU0738912210.USD","BK1518","IE00BMPRXN33.USD","LU1188198961.HKD","LU1303224171.USD","LU0210527791.USD","ODDS","LU0868486357.SGD","LU1481107354.HKD","LU0640798160.USD","06683","LU2294711473.HKD","LU0196878994.USD","LU0502904849.HKD","LU2362541273.HKD","LU2362541513.USD","03339","KWEB","BK1591","BK1609","BK1613","IE00B97KM107.HKD","SG9999014898.SGD","IE0008369823.USD","LU2399975544.HKD","LU1804176565.USD","HBBD.SI","LU2476274720.SGD","IE00B067MR52.USD","02269","01316","LU1242518857.USD","LU0140636845.USD","BK1103","IE0003851619.USD","LU0229945570.USD","002821","LU0642271901.SGD","LU0791591158.USD","LU1226288170.HKD","LU2362540622.SGD","LU0531971595.HKD","LU0359201885.HKD","LU0541501648.USD","LU0856984785.SGD","LU1504937902.USD","LU1807302812.USD","SGXZ86797644.SGD","LU0499858438.USD","IE00BF5LJ272.USD","HK0000286598.CNH","LU1196710864.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660461809","title":"CSPC Pharma Unit's Breast Cancer Drug Application Granted Priority Review in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2660461809","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660461809?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:50","pubTimestamp":1787050221,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group  said the new drug application for Anbenitamab in combination with its Docetaxel for Injection  was accepted by China's National Medical Products Administration.The drug, co-developed by unit Shanghai JMT-BIO Technology and Jiangsu Alphamab Oncology for the first-line treatment of advanced breast cancer, was also included in the priority review procedure.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0326950275.SGD","LU0501845795.SGD","LU1226288170.HKD","IE00BZ08YT58.USD","LU0072913022.USD","SG9999004220.SGD","LU1152091754.HKD","LU1328277881.USD","LU1993786604.SGD","LU2039709279.SGD","LU1008478684.HKD","IE00B543WZ88.USD","IE00BZ08YR35.GBP","LU1960683339.HKD","LU0880133367.SGD","01093","LU1813983027.USD","LU1152091168.USD","BK1521","IE00B031HY20.USD","LU0314109678.HKD","BK1191","BK1515","LU0315179316.USD","LU1226288253.USD","IE0008368742.USD","HK0000165453.HKD","IE00BZ08YS42.EUR","LU1951186391.HKD","LU0067412154.USD","LU1226287529.USD","LU1226287875.USD","LU0140636845.USD","IE00B5MMRT66.SGD","LU1226287792.SGD","LU1807302812.USD","KURE","IE0008369823.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123461158","title":"Beone Medicines Rises 1.34% With H1 Revenue Reaching 22.2 Billion Yuan as Global Expansion Accelerates","url":"https://stock-news.laohu8.com/highlight/detail?id=1123461158","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123461158?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:11","pubTimestamp":1787047890,"startTime":"0","endTime":"0","summary":"Beone Medicines closed at 293.78 yuan today, up 1.34%, with a trading volume of 1.736 billion yuan, a turnover rate of 5.147%, and a volume ratio of 0.71. The company's total market capitalization...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0228659784.USD","LU1251922891.USD","06160","BK0239","BK1588","BK4585","BK1500","BK1583","BK4526","688235","LU0588546209.SGD","LU2328871848.SGD","LU0307460666.USD","BK1161","LU1719994722.HKD","LU1770034418.SGD","KURE","LU1969619763.USD","ONC","BK4588","LU0828237510.HKD","BK4139","LU1303224171.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660146646","title":"Alphamab Oncology Says China NMPA Accepts Anbenitamab NDA for First-Line HER2+ Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660146646","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660146646?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:01","pubTimestamp":1787047294,"startTime":"0","endTime":"0","summary":"Alphamab Oncology says China NMPA accepts Anbenitamab NDA for first-line HER2+ advanced breast cancerChina’s NMPA accepted an NDA for anbenitamab (KN026) plus albumin-bound docetaxel HB1801 in first-l","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL8jzLgj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008369823.USD","IE00BZ08YT58.USD","LU1226287792.SGD","IE00BZ08YR35.GBP","LU1226287875.USD","LU1226288170.HKD","01093","LU0314109678.HKD","LU0880133367.SGD","LU0067412154.USD","LU1993786604.SGD","LU0140636845.USD","LU1226288253.USD","BK1515","LU1152091168.USD","09966","LU1807302812.USD","LU1008478684.HKD","LU1813983027.USD","LU0501845795.SGD","LU0326950275.SGD","LU1960683339.HKD","BK1161","IE00B5MMRT66.SGD","KURE","IE00B543WZ88.USD","LU0072913022.USD","LU0315179316.USD","LU1152091754.HKD","LU1951186391.HKD","SG9999004220.SGD","BK1191","BK1574","BK1521","IE00BZ08YS42.EUR","HK0000165453.HKD","IE0008368742.USD","LU2039709279.SGD","LU1226287529.USD","LU1328277881.USD","IE00B031HY20.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660483466","title":"CSPC Pharmaceutical - Kn026 and Hb1801 Combination Previously Granted Breakthrough Therapy Designation by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2660483466","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660483466?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:01","pubTimestamp":1787047263,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F01I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0326950275.SGD","LU2039709279.SGD","IE00BZ08YR35.GBP","IE0008368742.USD","LU1951186391.HKD","LU1226288253.USD","LU1960683339.HKD","LU1152091168.USD","LU0072913022.USD","01093","LU0314109678.HKD","LU1226288170.HKD","IE00BZ08YT58.USD","LU1226287529.USD","LU1813983027.USD","IE00B543WZ88.USD","IE00B031HY20.USD","IE00BZ08YS42.EUR","LU0067412154.USD","LU0140636845.USD","LU1328277881.USD","LU1993786604.SGD","LU1152091754.HKD","LU1226287875.USD","IE0008369823.USD","HK0000165453.HKD","LU0501845795.SGD","LU1807302812.USD","LU0315179316.USD","BK1521","LU1226287792.SGD","BK1191","KURE","BK1515","LU0880133367.SGD","LU1008478684.HKD","IE00B5MMRT66.SGD","SG9999004220.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660466107","title":"CSPC Pharmaceutical - Nda Indication: First-Line Treatment of Unresectable or Metastatic Her2-Positive Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660466107","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660466107?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:01","pubTimestamp":1787047263,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F01I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BZ08YT58.USD","LU1226287792.SGD","IE00B031HY20.USD","LU0326950275.SGD","LU1226287529.USD","SG9999004220.SGD","LU1152091168.USD","LU1993786604.SGD","LU1960683339.HKD","LU0072913022.USD","IE0008368742.USD","IE00B5MMRT66.SGD","IE0008369823.USD","IE00B543WZ88.USD","LU1951186391.HKD","IE00BZ08YR35.GBP","LU2039709279.SGD","LU1152091754.HKD","LU1807302812.USD","LU1226288170.HKD","LU1008478684.HKD","LU0314109678.HKD","BK1521","01093","LU1328277881.USD","LU0880133367.SGD","IE00BZ08YS42.EUR","BK1515","LU0501845795.SGD","LU0067412154.USD","LU1813983027.USD","KURE","LU0315179316.USD","LU1226287875.USD","LU1226288253.USD","LU0140636845.USD","HK0000165453.HKD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660457502","title":"WuXi Biologics Wins BioPharma APAC Spot on 2026 Sustainable Biopharma List","url":"https://stock-news.laohu8.com/highlight/detail?id=2660457502","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660457502?lang=en_us&edition=fundamental","pubTime":"2026-08-18 15:05","pubTimestamp":1787036714,"startTime":"0","endTime":"0","summary":"WuXi Biologics wins BioPharma APAC spot on 2026 sustainable biopharma listWuXi Biologics was named to BioPharma APAC’s “Top 26” sustainable biopharma companies list for 2026.Recognition cited its Gree","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLNFzYN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0043850808.USD","LU0029874061.USD","LU0348825331.USD","LU0348735423.USD","BK1589","02269","LU0823426480.USD","SG9999002562.SGD","BK1521","LU0979878070.USD","LU0039217434.USD","LU0181495838.USD","LU0588546209.SGD","LU0708995583.HKD","LU0320764599.SGD","LU0516422952.EUR","LU0516423091.SGD","LU1720050803.USD","LU0307460666.USD","LU0359201612.USD","LU0052750758.USD","BK1141","LU0572944931.SGD","LU0359202008.SGD","LU0051755006.USD","LU0819121731.USD","LU1688375341.USD","SG9999002463.SGD","LU0128526141.USD","LU0456827905.SGD","LU0516422366.SGD","LU0823426308.USD","LU1242518857.USD","KURE","LU1880383366.USD","LU0417516902.SGD","IE00B0JY6N72.USD","LU0417516738.SGD","LU3063872942.SGD","LU1242518931.SGD","LU2039709279.SGD","BK1576","LU0140636845.USD","LU0456846285.SGD","LU0516422440.USD","LU0856984785.SGD","LU0327786744.USD","LU0326950275.SGD","LU1794554557.SGD","BK1610"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660459040","title":"WuXi XDC Secures GMP Release for BCM3 Bioconjugate Production Line in Singapore","url":"https://stock-news.laohu8.com/highlight/detail?id=2660459040","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660459040?lang=en_us&edition=fundamental","pubTime":"2026-08-18 12:04","pubTimestamp":1787025881,"startTime":"0","endTime":"0","summary":"WuXi XDC secures GMP release for BCM3 bioconjugate production line in SingaporeWuXi XDC secured GMP release for its BCM3 bioconjugate production line at its Singapore site.Facility supports commercial","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL21820r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422366.SGD","LU0456827905.SGD","BK1589","LU0327786744.USD","LU0140636845.USD","LU1880383366.USD","LU0039217434.USD","LU0051755006.USD","LU0052750758.USD","LU2488822045.USD","BK1521","LU3063872942.SGD","LU0029874061.USD","LU0856984785.SGD","LU0516423091.SGD","LU0320764599.SGD","IE00B0JY6N72.USD","LU1720050803.USD","LU0417516738.SGD","LU1242518931.SGD","LU0181495838.USD","LU0417516902.SGD","LU0823426308.USD","SG9999002463.SGD","LU0128526141.USD","LU1688375341.USD","LU0979878070.USD","BK1576","LU0516423174.USD","LU0588546209.SGD","LU0572944931.SGD","LU0516422440.USD","LU0043850808.USD","02269","LU0823426480.USD","LU1794554557.SGD","LU0456846285.SGD","LU0359202008.SGD","LU2039709279.SGD","LU0708995583.HKD","SG9999002562.SGD","02268","LU0359201612.USD","LU0348735423.USD","LU0819121731.USD","LU0326950275.SGD","KURE","LU1242518857.USD","LU0307460666.USD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487988","title":"CSPC Innovation Posts RMB 1.26 Billion H1 Net Profit on RMB 3.24 Billion Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487988","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487988?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:19","pubTimestamp":1786969143,"startTime":"0","endTime":"0","summary":"CSPC Innovation posts RMB 1.26 billion H1 net profit on RMB 3.24 billion revenueCSPC’s subsidiary CSPC Innovation reported 1H 2026 revenue of RMB 3.24 billion, up 208.72% year on year.Net profit attri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL28Hkdn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03165","300765","LU0052756011.USD","LU0784383803.USD","HK0000165453.HKD","LU1104425308.USD","LU2114397693.USD","LU1863844665.USD","LU0661504455.SGD","LU2324357040.USD","IE00B543WZ88.USD","LU2091194634.USD","LU0211326839.USD","LU1960683339.HKD","LU0140636845.USD","LU1807302812.USD","LU1983299246.USD","LU0203347892.USD","IE00B5MMRT66.SGD","LU0882574055.USD","LU1061106388.HKD","LU1046234339.USD","LU2237443622.USD","LU0738911758.USD","01093","LU0315179316.USD","LU0784385840.USD","LU0920840948.USD","LU1267930813.SGD","BK1515","LU0390134368.USD","LU1226288253.USD","LU2237443895.HKD","SGXZ57979304.SGD","LU1226288170.HKD","LU0047473722.SGD","LU1261432733.SGD","LU2112291526.USD","LU1023059063.AUD","LU0964806797.USD","LU3187612489.SGD","AZN.UK","LU0128525689.USD","LU1196032939.SGD","KURE","LU1951186391.HKD","LU1267930490.SGD","LU0266013472.USD","LU1003077747.HKD","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192028422","title":"BlackRock Expands Stake in INNOVENT BIO with Recent Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1192028422","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192028422?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:17","pubTimestamp":1786965461,"startTime":"0","endTime":"0","summary":"According to the latest disclosure from the Hong Kong Stock Exchange, BlackRock increased its shareholding in INNOVENT BIO (01801) on August 12, acquiring 139,500 shares at a price of HKD 95.375 per...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","LU0320765489.SGD","LU2097828631.EUR","LU2097828557.USD","01801","BK4581","IE00B64PRP62.GBP","LU0157215616.USD","LU0648001328.SGD","LU0980610538.SGD","BK4567","LU0731783394.SGD","LU1599440770.SGD","LU0208291251.USD","LU0742537680.HKD","LU1969619763.USD","LU2097828474.EUR","IE00BGHQF748.EUR","LU1201861249.SGD","LU2430703095.HKD","LU2488822045.USD","IE00BVYPNW00.USD","BK1583","BK1161","LU0326950275.SGD","LU1481011671.HKD","LU2505996681.GBP","IE00B3PB1722.GBP","LU2097828805.USD","LU2592432038.USD","LU1509826696.USD","LU0772969993.USD","LU1670627923.USD","BK4504","LU0731783048.USD","LU1670628061.USD","BLK","BK4588","FDFF","LU2430703251.USD","LU1366333091.USD","LU0455707207.USD","BK4585","LU2505996509.AUD","LU2097828714.EUR","LU2264538146.SGD","LU1988902786.USD","HK0000165453.HKD","IE00BGHQF631.EUR","LU0070302665.USD","LU0130102774.USD","LU1064131342.USD","LU1481011911.USD","LU2242644610.SGD","LU0244354667.USD","LU0502904849.HKD","LU1188198961.HKD","LU2328871848.SGD","IE00BVYPNV92.GBP","LU1074936037.SGD","LU1291159041.SGD","LU0463099449.HKD","BK4534","LU0640476718.USD","LU1280957306.USD","IE00BDGV0183.EUR","BK4533","BK4535","BK1589","IE00B42XCP33.USD","EWH","KURE","LU2430703178.SGD","LU1989771016.USD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660553485","title":"CSPC Innovation Pharmaceutical H1 Net Profit 1.3 Billion Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=2660553485","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660553485?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:49","pubTimestamp":1786956561,"startTime":"0","endTime":"0","summary":"Aug 17 (Reuters) - CSPC Innovation Pharmaceutical Co., Ltd. <300765.SZ>::*H1 NET PROFIT 1.3 BILLION YUAN ($192.94 million)((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 17-AUG-202608:33:31 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nRSD7jdYvX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1152091168.USD","IE00BZ08YR35.GBP","BK1521","IE0008369823.USD","LU1993786604.SGD","BK1515","LU0326950275.SGD","IE00B543WZ88.USD","IE00BZ08YS42.EUR","LU1813983027.USD","LU1807302812.USD","LU1226287792.SGD","LU0067412154.USD","LU1226287529.USD","LU1951186391.HKD","LU1226288170.HKD","LU1152091754.HKD","IE0008368742.USD","LU0315179316.USD","LU1226288253.USD","SG9999004220.SGD","HK0000165453.HKD","IE00BZ08YT58.USD","BK1191","300765","KURE","LU1960683339.HKD","IE00B5MMRT66.SGD","BK0226","LU0072913022.USD","LU0140636845.USD","LU0314109678.HKD","01093","LU0880133367.SGD","LU1226287875.USD","LU1328277881.USD","LU2039709279.SGD","IE00B031HY20.USD","LU0501845795.SGD","LU1008478684.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660483149","title":"Wuxi Biologics (Cayman) Stock Rises 2.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2660483149","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660483149?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:31","pubTimestamp":1786955460,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. rallied 2.3% to 46.16 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.3% to 25453.23.Wuxi Biologics  Inc. closed 5.4% short of its 52-week high of HK$48.78, which the company achieved Aug. 10.Trading volume totaled 26.1 million shares, compared to the 50-day average of 34.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0181495838.USD","LU0588546209.SGD","LU0456846285.SGD","LU0052750758.USD","LU0140636845.USD","LU0516423174.USD","LU0979878070.USD","LU1720050803.USD","SG9999002562.SGD","IE00B0JY6N72.USD","LU0029874061.USD","LU0417516738.SGD","LU0708995583.HKD","LU0823426480.USD","LU0516422952.EUR","LU1242518857.USD","LU0359201612.USD","LU1688375341.USD","LU0348735423.USD","LU1794554557.SGD","LU0307460666.USD","LU3063872942.SGD","LU0417516902.SGD","SG9999002463.SGD","BK1610","02269","LU0516423091.SGD","LU1242518931.SGD","LU0359202008.SGD","LU2039709279.SGD","LU1880383366.USD","BK1141","BK1521","BK1589","LU0516422440.USD","LU0516422366.SGD","KURE","LU0856984785.SGD","BK1576","LU0326950275.SGD","LU0572944931.SGD","LU0051755006.USD","LU0320764599.SGD","LU0456827905.SGD","LU0819121731.USD","LU0327786744.USD","LU0039217434.USD","LU0128526141.USD","LU0823426308.USD","LU0043850808.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660483654","title":"WuXi Biologics Agrees to Sell 51.1% Stake in Bestchrom","url":"https://stock-news.laohu8.com/highlight/detail?id=2660483654","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660483654?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:29","pubTimestamp":1786955394,"startTime":"0","endTime":"0","summary":"WuXi Biologics agrees to sell 51.1% stake in BestchromWuXi Biologics entered a disposal arrangement to sell its 51.1% stake in Bestchrom to an independent third party.Closing is expected by December 2","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL5k1PMV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"WuXi Biologics Agrees to Sell 51.1% Stake in Bestchrom","news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","LU0348735423.USD","LU0326950275.SGD","LU0823426308.USD","LU1242518857.USD","LU0856984785.SGD","LU0417516902.SGD","LU1794554557.SGD","BK1521","BK1576","SG9999002463.SGD","LU3063872942.SGD","LU0819121731.USD","KURE","LU0456827905.SGD","LU0348825331.USD","LU0823426480.USD","LU0043850808.USD","LU0181495838.USD","LU0979878070.USD","LU0052750758.USD","LU0359202008.SGD","SG9999002562.SGD","LU0588546209.SGD","02269","LU0417516738.SGD","LU0708995583.HKD","LU0307460666.USD","LU0327786744.USD","LU1880383366.USD","LU0029874061.USD","LU0516422952.EUR","LU1688375341.USD","LU1242518931.SGD","LU0516423091.SGD","LU0516423174.USD","LU0128526141.USD","LU0572944931.SGD","LU0516422366.SGD","LU0359201612.USD","IE00B0JY6N72.USD","LU0039217434.USD","LU0320764599.SGD","LU0456846285.SGD","LU0516422440.USD","LU2039709279.SGD","LU0140636845.USD","BK1589","BK1610","LU1720050803.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110314526","title":"JPMorgan Chase & Co. Increases Stake in BEONE MEDICINES by Over 4.1 Million Shares at Approximately HKD 219.79 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1110314526","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110314526?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:51","pubTimestamp":1786708275,"startTime":"0","endTime":"0","summary":"Data from the Hong Kong Stock Exchange shows that on August 11, JPMorgan Chase & Co. increased its holdings in BEONE MEDICINES (06160) by 4,119,720 shares.The transaction was executed at an average...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310799852.SGD","LU0211326839.USD","LU1116320737.USD","LU1719994722.HKD","LU2236285917.USD","LU2237443549.SGD","LU1244550494.USD","LU1668664300.SGD","LU0971096721.USD","LU1894683348.USD","LU0820561818.USD","LU1244550577.SGD","LU0234570918.USD","LU2106854487.HKD","IYF","SG9999002232.USD","KBWB","IE00BWXC8680.SGD","LU0787776722.HKD","LU1629891620.HKD","LU0868494708.USD","XLF","LU0683600562.USD","LU0320765489.SGD","LU2237443978.SGD","BK4550","LU0868494617.USD","LU2023250843.SGD","IE0034235188.USD","JPMO","IE00BKVL7J92.USD","IE00BBT3K403.USD","LU0256863902.USD","06160","LU1496350171.SGD","LU0320765646.SGD","BK1161","LU0070302665.USD","LU1894683264.USD","LU1917777945.USD","LU0106831901.USD","LU1162221912.USD","LU1363072403.SGD","IE00B3S45H60.SGD","IE00BJLML261.HKD","LU1119994496.HKD","LU2430703251.USD","BK4533","IE00BDCRKT87.USD","LU2417539215.USD","LU1267930490.SGD","LU0345769631.USD","LU2328871848.SGD","LU0265550359.USD","LU1548497426.USD","LU2430703178.SGD","LU0211326755.USD","JPO","TFNS","LU0203347892.USD","LU0496365809.HKD","LU0964807845.USD","LU0208291251.USD","BK1588","IE00BK4W5M84.HKD","LU2244417387.USD","LU2756315664.SGD","IYG","LU0256863811.USD","LU0417517546.SGD","LU0828237510.HKD","LU1303224171.USD","LU1720051108.HKD","LU2264538146.SGD","IE00B1XK9C88.USD","BK0239","BK4207","LU0942090050.USD","LU1770034418.SGD","LU0976567544.SGD","FNCL","LU1145028129.USD","LU0211331839.USD","IE0034235295.USD","LU1084165304.USD","IE00BJTD4V19.USD","IE0034235303.USD","LU0228659784.USD","IE00BZ1G4Q59.USD","BK4582","KURE","LU0211327993.USD","LU2237443382.USD","BK4526","LU0640476718.USD","LU2237443465.HKD","LU2023250504.SGD","BK1583","LU0820561909.HKD","BK4534","LU1670628061.USD","BK4566","IE00BHPRN162.USD","UYG","LU2357305700.SGD","IE00B775SV38.USD","BK4139","LU1244550221.USD","IXG","IE00BLSP4452.SGD","LU1551013342.USD","LU2357627491.SGD","LU2456880835.USD","LU2746668974.SGD","LU1251922891.USD","IE00BDRTCR15.USD","688235","IE00BN8TJ469.HKD","IE00BLSP4239.USD","LU0882574139.USD","LU2237443895.HKD","BK4581","LU2211815571.USD","LU0203345920.USD","LU0149725797.USD","LU0267386448.USD","LU1914381329.SGD","BK4588","LU2505996681.GBP","LU1720051017.SGD","LU2552382058.USD","LU0323591593.USD","LU2552382132.HKD","LU0588546209.SGD","LU0238689110.USD","BK4585","LU1366192091.USD","LU0307460666.USD","BK1500","VFH","IE00B1BXHZ80.USD","LU0048584097.USD","LU0234572021.USD","BK4504","LU0215105999.USD","LU1988902786.USD","LU0345770308.USD","LU0251132253.USD","LU1496350502.SGD","ONC","FTXO","LU2242649171.HKD","IE00BJTD4N35.SGD","IE000M9KFDE8.USD","PGF","LU0943347566.SGD","LU0187121727.USD","LU2237443622.USD","LU1974910355.USD","LU2381873111.SGD","LU2462157665.USD","LU2552382215.SGD","LU2592432038.USD","IE00BFXG1179.USD","LU0820562030.AUD","LU0006306889.USD","LU0170899867.USD","LU0265550946.USD","LU1116320901.HKD","LU1551013425.SGD","LU2213496289.HKD","LU2430703095.HKD","LU1064131342.USD","LU2023250330.USD","JPM","LU1969619763.USD","LU0345770993.USD","LU0689472784.USD","LU2054465674.USD","EWH","JPX","LU0345769128.USD","SG9999002224.SGD","TRUF","LU0211328371.USD","LU1280957306.USD","LU0106261372.USD","IE00BKDWB100.SGD","LU1670627923.USD","LU1261432733.SGD","LU2505996509.AUD","IE00BK4W5L77.USD","BK4516","LU0859254822.USD","JPMLL","LU2746668461.USD","LU2756315318.SGD","LU1032466523.USD","IE00BYXW3230.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}